Stocks
318240PTRY
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare diseases, with a focus on genetic disorders. Its pipeline includes investigational treatments targeting unmet medical needs, and investors track it for potential regulatory milestones and partnership opportunities.
Congressional Interest in 318240 (PTRY)
1 member of Congress has disclosed 1 trade in 318240 (PTRY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading PTRY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-05-21 | MICHAEL T. MCCAUL | sell | $1K-$15K |